4th Pharmacovigilance 2013
01/08/2013

Virtue Insight Ltd is pleased to announce “4th Pharmacovigilance 2013”.The theme for this event is “safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management.”

Online PR News – 08-January-2013 – Redbridge, Ilford – 4th Pharmacovigilance 2013

“Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management"

March 12th & 13th 2013, Hotel Marriott, London UK

For more info on the event and for event brochure kindly visit –
http://www.virtueinsight.com/pharma/4th-Pharmacovigilance-2013/

Key Themes Discussed at this Conference:

• Exploiting the latest technologies, methodologies and introducing pharmacy automations on work practices of Pharmacovigilance in EU, US and Asia
• Impact of the new European Pharmacovigilance legislation - Implementation and Beyond
• Keeping abreast of the changes impacting the drug safety industry to ensure the pharmacovigilance strategies are robust and geared to compliance
• Recent successful strategies and business models to bring out new medicines
• How will PV activities change with Clinical Trial Transformation Initiative?
• Discover approaches for collecting, integrating and analyzing all of the safety data generated from preclinical models
• Identifying essential antidote requirements and learn to implement best practices in drug safety and surveillance
• Exploiting the pharmacy automations and technologies for enhancement of medication safety
• Impact of technology – learn and explore
• Latest developments in pharmacovigilance, drug safety and risk management to ensure safer drugs to market
• Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
• Determining the steps and strategies for enhancing quality in healthcare
• Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
• Review the use of Periodic Safety Update Reports (PSURs) post-authorisation for safety signals
• Dwell ahead of regulatory developments & improving your risk management strategies in a cost effective way in EU, US and Asia
• Updating yourself with respect to terms of legislation, policies, systems, technology, communication strategies and best practice in PV
• Accelerating new medicine introduction in developing world & overcoming challenges
• Explaining how to use the data sources and observational research for effective safety analysis
• Good supply chain management practices for medicine distribution
• Be part of a major networking opportunity.

Key Speakers Include:
• Julia Appelskog, Pharmacovigilance Country Lead, Merck
• William Gregory, Director, Safety & Risk Management, Pfizer
• Christina Strom Moller, VP Patient Safety Late Development & Marketed Products, Europe, AstraZeneca
• John Parkinson, Director CPRD, MHRA
• Mustafa A. Zaman, Senior Consultant – Integrated Product Development (IPD), Parexel
• Astrid Herpers, Regional PV Director Western Europe, Boehringer Ingelheim
• Sumit Munjal, Oncology Physician & EU Region Medical Advisor –Pharmacovigilance Millennium, Takeda Oncology Company
• Ashok Srivastava, Medical Oncologist/ Hematologist, CMO & Chief Safety Officer Owner & President, Global PharmaTek (USA)
• Pipasha Biswas, Chairperson, Drug Safety & Pharmacoigilance Committee, Director & QPPV Pharmacovigilance & Pharmacoepidemiology, Symogen
• Stephanie Jones, Medical Director, Medicorum
• Shelley Gandhi, Director - Pharmacovigilance & Drug Safety, NDA Regulatory Services
• Saad Shakir, Director, Drug Safety Research Unit
• John Whitebrook, Director, Deloitte Consulting
Plus Many More...

Who Should Attend:

VPs, Directors, Heads, Managers, Scientific Advisors, Consultants of:-
• Pharmacovigilance
• Pharmacoepidemiology
• Pharmacogenomics
• Drug/Product Safety
• Drug Development
• Information and Clinical Data Management
• Clinical Pharmacology
• Clinical Safety
• Periodical safety update reports
• Risk Management
• Research & Development
• Quality Assurance
• Patient Safety
• Signal Detection
• Safety Surveillance
• Outcomes Research
• Data Analysis
• Epidemiology
• Medical Affairs
• Regulatory Affairs and Compliance
• Information technology
• Sales and Marketing

Why Should You Attend:
4th Pharmacovigilance 2013– “Uniting “Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management"
Get more from the event, with a broader scope bringing the whole communications value chain together? Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference. Whether you are on the branded or generic side, you cannot afford to miss this opportunity to benchmark your tactics and strategies against the industry leaders who will be the first to traverse the pathway. Devise an immediate action plan for your biosimilar prosecution and litigation strategies in light of the barriers to entry, research and development costs, and regulatory hurdles, which are balanced against an enormous potential for increased profit margins.

Conference Booking Details:-

Introductory Offer (3 delegate places for the price of 2):- A huge saving of £900 - (Limited seats left) - You can simply email or call and book your conference delegate seats on TEL: + 44 20 3302 4659. TEL (India): + 91 44 4213 8101. Email – gunavathi@virtueinsight.com

Super Early Discount (Till 12th January 2013):- Conference Delegate Pass (£ 500 + VAT per delegate) – You can simply email or call and book your conference delegate seats on TEL (UK): + 44 20 3302 4659. TEL (India): + 91 44 4213 8101. Email – gunavathi@virtueinsight.com

Early Discount (13th January 2013– 12th February 2013):- Conference Delegate Pass (£ 700 + VAT per delegate) – You can simply email or call and book your conference delegate seats on TEL (UK): + 44 20 3302 4659. TEL (India): + 91 44 4213 8101. Email – gunavathi@virtueinsight.com

Standard Registration (After 13th February 2013):- Conference Delegate Pass (£ 900 + VAT per delegate) – You can simply email or call and book your conference delegate seats on TEL (UK): + 44 20 3302 4659. TEL (India): + 91 44 4213 8101. Email – gunavathi@virtueinsight.com

Conference Sponsor & Exhibition Stall – Should you wish to Sponsor, or purchase a Exhibiton Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to – TEL (UK): + 44 20 3302 4659. TEL (India): + 91 44 4213 8101. Email – gunavathi@virtueinsight.com

Greetings from Gunavathi,
I am happy to invite you for our conference "4th Pharmacovigilance 2013" which is going to be held on 12th & 13th March, Hotel Marriott, London UK.
Come and join us for some intense and interactive panel debates, top level presentations and the chance to network with senior professionals from across the industry.
This conference will provide an important platform for pharmacovigilance stakeholders across the world to discuss and share best practices in expediting pharmacovigilance development. 4th Pharmacovigilance 2013 is the latest in Virtue Insight’s series of successful pharmacovigilance events.

Kindly visit: http://www.virtueinsight.com/pharma/4th-Pharmacovigilance-2013/.
We are also organising an event on Biosimilars Congregation 2013 on 19th and 20th Feb. 2013 in London, UK. For more information please feel free to contact gunavathi@virtueinsight.com